최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한중풍·순환신경학회지 = The journal of the society of stroke on korean medicine, v.22 no.1, 2021년, pp.45 - 56
하원정 (경희대학교 대학원 임상한의학과) , 서유나 (경희대학교 대학원 임상한의학과) , 이영선 (경희대학교 대학원 임상한의학과) , 조기호 (경희대학교 한의과대학 순환신경내과학교실) , 문상관 (경희대학교 한의과대학 순환신경내과학교실) , 정우상 (경희대학교 한의과대학 순환신경내과학교실) , 권승원 (경희대학교 한의과대학 순환신경내과학교실)
■ Background Heart Failure with Preserved Ejection Fraction(HFpEF) is a heart failure that appears to have normal contraction function. In the case of HFpEF, no pharmacological therapy has been found to improve clinical prognosis, so it should be approached as an symptomatic treatment, theref...
Kim YD. Heart Failure with Preserved Ejection Fraction: Current Diagnostic and Therapeutic Approach. 2016;90(1):20-25.
Park JJ, Choi DJ. Treatment of Heart Failure with Reduced Ejection Fraction: Current Update. Korean J Med. 2015;88(2):127-134.
Bennett JA, Riegel B, Bittner V, Nichols J. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung. 2002;31(4):262-70.
Na SJ, Bae SH. Optimal Management of Heart Failure with Preserve Ejection Fraction. Korean J Med. 2015;88(2):135-141.
Lee JH, Koo BK. Pleural Effusion in Cardiovascular Disease. Korean J Med. 2011;81(2):161-166.
조기호, 권승원. 경계 너머의 한방처방. 경기:물고기숲. 2012:201.
張仲景. 元.鄧珍本金?要略2-4b~2-5a. 燎原書店復刻版. 1988. 86-87.
EZAKI H, INOKUCHI T, TANIWAKI M, YAMAMOTO H, DOI H, MIYAKE T, SAKURADA M. Efficacy of Mokuboito in Patients with Severe Intractable Heart Failure. Kampo Medicine. 2016;67(2):169-177.
Otsuka,K. Kampo-lgaku(漢方??), Osaka:Sougen-sha. 1973:150.
조한진, 이경섭. 목방기탕(木防己湯)이 강심이뇨 및 심장박동에 미치는 영향. 대한한의학회지. 1984;5(1): 28-34.
Seiichiro Nishida, Hiroyasu Satoh. Vascular Pharmacology of Mokuboito (Mu-Fang-YiTang) and Its Constituents on the Smooth Muscle and the Endothelium in Rat Aorta. eCAM. 2007;4(3):335-341.
Nishida S, Satoh H. Vascular pharmacology of mokuboito(mu-fang-yi-tang) and its constituents on the smooth muscle and the endothelium in rat aorta. Evid Based Complement Alternat Med. 2007;4:335-341.
Satoh H, Sperelakis N. Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen Pharmacol. 1998;30:451-463.
한의과대학 방제학교수 공편저. 방제학. 서울:영림사; 2003:504-6.
Ito Y. Pathophysiology of the Goreisan show lowering of osmolality set point. Japanese Journal of Oriental Medicine. 1978;28:91-9.
Isohama Y. Modulation of aquaporin water channel function by Kampo medicines. Kampo and the newest therapy. 2008;17:27-35.
Kurita T, Nakamura K, Tabuchi M, Orita M, Ooshima K, Higashino H. Effects of Goreisan: a traditional Japanese Kampo medicine, on aquaporin 1, 2, 3, 4 and V2R mRNA expression in rat kidney and forebrain. J Med Sci. 2011;11(1):30-8.
Kim SY. Influence of Goryeosin infusion solution on the change of serum electrolytes in rats. Dajeon Univ 1990:1-38.
Hirotaka Ezaki, Makoto Ayaori, Hiroki Sato, Yoshio Maeno, Masanori Taniwaki, Takayuki Miyake, Masami Sakurada. Effects of Mokuboito, a Japanese Kampo medicine, on symptoms in patients hospitalized for acute decompensated heart failure - A prospective randomized pilot study. Journal of Cardiology. 2019;74:412-417.
Shuji YAKUBO, Yuko KINOSHITA, Yasuyuki ARAKAWA, Masanao TAKA-HAsHI, Susumu KITANAKA. Clinical evaluation of Moku-boi-to(Mu-Fang-Yi-Tang):A Japanese and Chinese traditional medicine for heart failure. J.Trad.Med. 2002;19:159-163.
Hirotaka Ezaki, Makoto Ayaori, Hiroki Sato, Yoshio Maeno, Masanori Taniwaki, Takayuki Miyake, Masami Sakurada. Effects of Mokuboito, a Japanese Kampo medicine, on symptoms in patients hospitalized for acute decompensated heart failure - A prospective randomized pilot study. Journal of Cardiology. 2019;74:412-417.
Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, Ulmer H. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest. 2012;42:153-163.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.